Arca
Skip to content

K-Assay C-Reactive Protein (3), K-Assay Crp Multi-Calibrator D, K-Assay Crp Multi-Calibrator E, K-Assay Crp Multi-Calibr

C-Reactive Protein, Antigen, Antiserum, And Control. 510(k) K023828, from Kamiya Biomedical Co. (Seattle, WA). Product code DCK, class 2.

As of Nov 17, 2026, K023828 is an FDA 510(k) held by Kamiya Biomedical Co., substantially equivalent on Feb 4, 2003 after 78 days, with 1 recall tied to it in FDA's recall database.

  • Substantially equivalent: Feb 4, 2003
  • Review time: 78 days
  • Recalls: 1
  • Cited as a predicate by: 3 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The K-ASSAY ® CRP (3) is intended to be used as a high sensitive assay for the quantitative determination of CRP in serum and plasma by immunoturbidimetric assay. Measurement of C-Reactive Protein aids in the detection and evaluation of tissue injury, inflammatory disorders, and related diseases.

Cited as a Predicate

3 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K023828, newest first; each opens FDA's recall record
StartedReasonStatus
May 1, 2009Z-0973-2010The long-term stability of level 2 (1.0 mg/dL) may not be within the specifications due to a decrease in CRP concentration.Terminated

Other DCK Clearances

The newest 510(k)s for the same product code; see every DCK device

Record

Type
Traditional
Received
Nov 18, 2002
Review panel
Immunology
Regulation
21 CFR 866.5270

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.